Nadir Godrej will step down as chairperson across three listed Godrej Group companies — Godrej Industries, Godrej Agrovet and Astec LifeSciences — as he approaches the age of 75 in August 2026, in line with disclosures made to the stock exchanges.
The transition marks a significant leadership reshuffle within the Godrej Group, with successor appointments already approved by the respective boards. The changes will come into effect from August 14, 2026.
At Godrej Industries, the Nomination and Remuneration Committee (NRC) and the Board have approved the appointment of Pirojsha Godrej as Chairperson of the Board and Chairperson of the Godrej Industries Group. He has been designated as “Chairperson-Designate” with immediate effect, paving the way for a structured transition at the group’s flagship entity.
Meanwhile, at Godrej Agrovet, the Board has approved the appointment of Burjis Godrej, currently Executive Director, as the Chairperson effective August 14, 2026. He has also been designated as “Chairman-Designate” from April 13, 2026. Burjis Godrej, son of Nadir Godrej, is eligible under the Companies Act and SEBI regulations to take on the role and is not debarred from holding directorship positions.
Astec LifeSciences, a subsidiary of Godrej Agrovet, has also seen Nadir Godrej step down from the chairperson position, completing the leadership transition across the three listed entities.
Nadir Godrej has been a key figure in the growth and strategic direction of the Godrej Group, particularly in its listed businesses spanning chemicals, agriculture, and allied sectors. His stepping down signals a generational shift within the group, with the next line of leadership taking charge across core businesses.
The transition appears to have been planned in advance, with clear succession structures and designated leadership already in place to ensure continuity across operations and governance.